Meniere's Disease PDF
-
Upload
fuji-seprinur-hidayat -
Category
Documents
-
view
225 -
download
0
Transcript of Meniere's Disease PDF
-
8/12/2019 Meniere's Disease PDF
1/22
5/31/10 3:2Meniere's disease
Page 1ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Official reprint from UpToDatewww.uptodate.com
2010 UpToDate
AuthorsElizabeth A Dinces, MD
Steven D Rauch, MD
Section EditorDaniel G Deschler, MD, FACS
Deputy EditorPracha Eamranond, MD, MPH
Meniere's disease
Last literature review version 18.1:January 2010 | This topic last updated:November 9, 2009
INTRODUCTION Meniere's disease is a condition that is thought to arise from abnormal fluid and
ion homeostasis in the inner ear. The disease is named for Prospere Meniere, a French physician who
first reported that the inner ear could be the source of a syndrome manifesting episodic vertigo,
tinnitus, and hearing loss [1].
The classic pathologic lesion of Meniere'sdisease is termed endolymphatic hydrops. This lesion can be
definitively diagnosed only by postmortem histopathologic analysis of the temporal bone. However,hydrops has also been identified in postmortem examination of temporal bones where there was no
history of Meniere symptoms.
Meniere's disease refers to presentation of the typical set of symptoms with an idiopathic etiology. Th
symptomatic triad may also occur secondary to other inner ear disorders, in which case it is termed
Meniere's syndrome. The symptom triad may be a final common pathway of many different inner ear
insults.
This topic will present an overview of the diagnosis and treatment of Meniere's disease. More detailed
topics addressing the differential diagnosis of vertigo, tinnitus, and hearing loss are presented
separately. (See "Evaluation of vertigo"and "Pathophysiology, etiology, and differential diagnosis ofvertigo"and "Etiology of hearing loss in adults"and "Sudden sensorineural hearing loss"and
"Pathogenesis and diagnosis of tinnitus".)
EPIDEMIOLOGY Meniere's disease can begin at any age but patients typically present with
symptoms between the ages of 20 and 40. Meniere's syndrome in children is most often associated
with congenital malformations of the inner ear [2,3].
The precise incidence of Meniere's diseaseis difficult to determine because of nonstandard criteria for
diagnosis, but the reported incidence ranges from 10 to 150 per 100,000 persons [4]. Bilateral diseas
occurs in 10 to 50 percent of patients, with most reports quoting a 25 to 35 percent risk [5-7].
PATHOGENESIS Meniere's disease is associated with endolymphatic hydrops with distortion anddistention of the membranous, endolymph-containing portions of the labyrinthine system. Although
most patients have no identifiable other underlying otologic disease, multiple potential causes of
endolymphatic hydrops have been proposed (table 1).
It is unclear why excess fluid builds up in the endolymphatic spaces of the inner ear. Several theories
have been proposed, but all remain unproven. Lack of a single etiologic theory for Meniere's disease
may reflect underlying clinical and genetic heterogeneity [8].
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=PC%2F20826http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=5-7http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=2%2C3http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=genneuro/7125&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/5112&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=genneuro/7125&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/5958&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=genneuro/7125&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=genneuro/7125&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=1http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8http://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=PC%2F20826http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=5-7http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=4http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=2%2C3http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/8404&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/5958&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/5112&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=genneuro/7125&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=genneuro/2118&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=1http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/online/content/author.do?topicKey=prim_ent%2F9407http://www.uptodate.com.offcampus.lib.washington.edu/ -
8/12/2019 Meniere's Disease PDF
2/22
5/31/10 3:2Meniere's disease
Page 2ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Proposed etiologies include:
Blockage at the endolymphatic sac or duct One popular theory postulates an abnormality in the
resorption of endolymph at the endolymphatic sac. Endolymphatic hydrops has been experimentally
induced in guinea pigs by blocking the entrance to the endolymphatic sac [9].
Hypoplasia of the vestibular aqueduct [10].
An immunologic mechanism [11-13].
A genetic predisposition An autosomal dominant inheritance pattern has been reported, involving
8 to 15 percent of patients with Meniere's disease in two studies [14,15]. Patients with a family histor
had an earlier age of onset and the manifestations were more severe in successive generations [14].
specific gene marker has not been identified.
A viral etiology [16] Although a viral etiology has been proposed, DNA for suspected viruses
(herpes simplex, varicella zoster, and cytomegalovirus) has not been detected in endolymphatic
samples taken at surgery for patients with Meniere's disease [17].
A vascular etiology Migraine occurs more commonly in patients with Meniere's disease than in
the general population, leading to the postulation of a common vascular pathophysiology for the two
disorders [18,19].
The mechanism responsible for symptoms of Meniere's disease is also unknown. While endolymphatic
hydrops is present in all patients with Meniere's disease, not all patients with endolymphatic hydrops
have symptoms.
The "rupture theory", elaborated 40 to 50 years ago [20,21], proposes that rupture of the dilated
endolymphatic sac allows potassium-rich endolymph into the perilymphatic space. The resulting
biochemical gradient depolarizes the cochlear and vestibular hair cells, resulting in acute loss of
function. Once pressure between the endolymphatic and perilymphatic space is equalized, the
membrane rupture can seal over. Ion "pumps" restore the normal gradient and hair cell function.
Repeated ionic insults eventually lead to degeneration of the hair cells. Cytologic changes in hair cells
with potassium ion intoxication have been demonstrated [22]. However, the rupture theory has been
called into question [23].
CLINICAL FEATURES The clinical features of Meniere's disease include the following:
Episodic vertigo (a true spinning sensation that has an onset and an offset)
Sensorineural hearing loss
Tinnitus
Meniere's disease is diagnosed only if patients complain of both episodic vertigo and sensorineural
hearing loss. Aural fullness and nausea may be seen in conjunction with these symptoms. Affected
patients tend to cycle from active symptoms to prolonged remissions. (See 'Diagnosis'below.)
Vertigo is characteristically rotatory spinning or a rocking sensation and may be associated with nause
and vomiting, and persists from 20 minutes to 24 hours duration [24]. Additional sensations of
disequilibrium or other patterns of dizziness are seen in about 15 percent of cases. (See "Evaluation o
vertigo".)
Hearing loss is sensorineural, usually fluctuating, and often initially affects the lower frequencies.
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=genneuro/2118&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=24http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H5http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=23http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=22http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=20%2C21http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=18%2C19http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=17http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=16http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=14http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=14%2C15http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=11-13http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=10http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=9 -
8/12/2019 Meniere's Disease PDF
3/22
5/31/10 3:2Meniere's disease
Page 3ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Hearing loss progresses over time, and often results in permanent hearing loss at all frequencies in th
affected ear over an 8 to 10 year period. (See "Etiology of hearing loss in adults".)
Downward fluctuations in hearing are typically associated with intense aural fullness or pressure in the
ear or the side of the head [24].
Tinnitus is characteristically low pitch (like listening to a seashell or machinery) and may be associated
with auditory distortion. (See "Pathogenesis and diagnosis of tinnitus".)
The course of Meniere's disease varies among individuals. Some patients have marked hearing
fluctuation and progressive hearing loss with infrequent vestibular symptoms; some have severe and
frequent vertigo with only mild auditory symptoms; and some manifest both auditory and vestibular
symptoms in equal measure. Approximately two-thirds of patients experience vertigo attacks in
clusters, while one-third have sporadic attacks. The frequency of vertigo episodes may decline over
time [25].
DIAGNOSIS The presumed diagnosis of endolymphatic hydrops is based upon clinical symptoms.
There is no specific diagnostic test for Meniere's disease and a definitive diagnosis can only be made
postmortem.
The clinical diagnosis in most patients is based upon the history, neurotologic evaluation, and clinicalresponse to medical management. Patients usually have some variable auditory and/or vestibular
symptoms for three to five years before they meet the diagnostic criteria for Meniere's disease.
Diagnostic criteria proposed by the American Academy of Otolaryngology and Head and Neck Surgery
(AAO-HNS) stipulate that a "definite" diagnosis of Meniere's disease requires the following [26]:
Two spontaneous episodes of rotational vertigo lasting at least 20 minutes
Audiometric confirmation of sensorineural hearing loss
Tinnitus and/or a perception of aural fullness
Further investigation is also required to rule out other disorders in the differential diagnosis. (See
'Differential diagnosis'below.)
Audiometry Audiometry should be performed in all patients with suspected Meniere's disease. The
most common audiometric pattern in early Meniere's disease is a low frequency or combined low and
high frequency sensory loss with normal hearing in the mid frequencies. Over time the hearing loss
"flattens out."
Vestibular testing Vestibular testing may be normal early in the course, but will eventually be
abnormal on the affected side. Testing is primarily useful in determining candidacy for interventional
treatments or identifying possible bilateral disease.
A standard vestibular evaluation includes electronystagmography (ENG), rotary chair testing, and
computerized dynamic posturography. With progression of Meniere's disease, both the ENG and rotary
chair test should show evidence of declining peripheral vestibular function in the affected ear. The ENG
(particularly the caloric test, in which the ear canals are irrigated with warm and cool water to
stimulate the inner ear) is more sensitive for inner balance dysfunction, but the rotary chair test is
more specific.
Laboratory testing Blood testing includes a search for suspected comorbid conditions (table 2) an
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=PC%2F20819http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H11http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=26http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=25http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/8404&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=24http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/5112&source=see_link -
8/12/2019 Meniere's Disease PDF
4/22
5/31/10 3:2Meniere's disease
Page 4ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
an RPR test for syphilis. (See "Diagnostic testing for syphilis".)
Tests for antibodies against inner ear antigens have been described [27-29], but are not considered t
be clinically useful and are not part of a routine evaluation for Meniere's disease.
Imaging studies Magnetic resonance imaging (MRI) can identify features that support a diagnosis
of Meniere's disease, but the findings are not diagnostic [30]. Nevertheless, MRI is usually indicated t
rule out central nervous system (CNS) lesions that can mimic Meniere's disease, including CNS tumor
aneurysms, or stenosis of the posterior circulation, Arnold-Chiari malformations, and findingssuggesting multiple sclerosis. (See 'Differential diagnosis'below.)
Tests for endolymphatic hydrops Specific tests for endolymphatic hydrops include glycerine, urea
or sorbitol"stress" tests [31], and electrocochleography [32]. These tests have low sensitivity and
specificity and their role in the diagnosis and management of Meniere's disease is controversial.
The vestibular evoked myogenic potential (VEMP) is a newer test that shows promise for diagnosis and
monitoring [33]. VEMP is an inhibitory sacculocollic reflex test that shows characteristic changes in
symptomatic ears of Meniere patients [33], and may detect early saccular hydrops before the onset o
classic Meniere's symptoms [34]. In addition to diagnosis, VEMP may be useful for monitoring patient
for disease progression, and to identify the active ear in patients with bilateral disease.
DIFFERENTIAL DIAGNOSIS Conditions that need to be considered when Meniere's disease is
suspected include (table 3):
Vestibular schwannoma Patients with vestibular schwannoma (acoustic neuroma) typically
present with progressive asymmetric hearing loss but can sometimes have fluctuating hearing loss.
Such patients rarely have true vertigo but may complain of imbalance. Occasional patients will have
tinnitus and imbalance with normal hearing. Auditory brainstem response (auditory evoked response)
testing and MRI in patients with vestibular schwannoma show abnormalities indicating compression of
the eighth nerve complex. (See "Vestibular schwannoma (acoustic neuroma)".)
Multiple sclerosis Multiple sclerosis (MS) can present with symptoms identical to those of
Meniere's disease. However, the observed nystagmus during an attack of MS is typically more severe
and longer lasting, and the patients may have other neurologic complaints. Central abnormalities are
seen on electronystagmogram testing (which is typically normal in early Meniere's disease). White
matter lesions may be seen on MRI and cerebrospinal fluid abnormalities may be detected. (See
"Diagnosis of multiple sclerosis in adults".)
Transient ischemic attack Transient ischemic attacks (TIAs) are typically of shorter duration tha
Meniere's attacks. In addition, patients with TIAs rarely experience simultaneous vestibular and
cochlear symptoms, and TIAs do not cause persistent tinnitus or objective hearing loss. (See "Initial
evaluation and management of transient ischemic attack and minor stroke".)
Migraine Migraine-associated vertigo is an important consideration, especially those with a
history of migraine headache and in young patients with new onset of episodic vertigo [35]. The
prevalence of migrainous vertigo is approximately 3 to 5 percent in the general population, far higher
than the 0.2 percent prevalence of Meniere's disease in the US population [36]. Migraine must always
be considered as an alternative or confounding illness.
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=36http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=35http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=cva_dise/6023&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=demyelin/4438&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=brain_ca/7535&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=PC%2F21034http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=34http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=33http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=33http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=32http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=31http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/245684&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H11http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=30http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=27-29http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=stds/5643&source=see_link -
8/12/2019 Meniere's Disease PDF
5/22
5/31/10 3:2Meniere's disease
Page 5ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Headache is usually present with migrainous vertigo, either during the episode or afterwards (when
vertigo or tinnitus is a migraine aura). Migrainous vertigo is often accompanied by photophobia or
phonophobia, symptoms not seen in vertigo episodes associated with Meniere's disease. Diagnostic
criteria include episodic vestibular symptoms, and at least two migraine symptoms (migrainous
headache, photophobia, phonophobia, or visual or other aura) occurring during at least two vertiginou
episodes [37]. (See "Migrainous vertigo".)
Successful treatment with tryptans during an attack is generally diagnostic, although migrainous
vertigo is less responsive than headaches. A decrease in the frequency of events with migraine
prophylaxis supports the diagnosis of migrainous vertigo. (See "Pathophysiology, clinical
manifestations, and diagnosis of migraine in adults".)
Other Diabetes and thyroid disease can sometimes cause symptoms that have some overlap wit
Meniere's disease. Hearing complaints and/or tinnitus are usually bilateral in these conditions and the
patients often have chronic imbalance instead of attacks of true vertigo. Similar symptoms may occur
in patients with severe anemia. Appropriate testing can diagnose these conditions.
Cogan's syndrome is a chronic inflammatory condition that occurs most commonly in young adults an
can include vestibuloauditory symptoms that are similar to Meniere's disease. The diagnosis is typicall
raised by the constellation of symptoms associated with Cogan's syndrome, including eye disease and
systemic vasculitis. (See "Cogan's syndrome".)
PRINCIPLES OF TREATMENT Meniere's disease should be considered a chronic condition;
treatment may successfully relieve symptoms but does not address the underlying abnormal
pathophysiology.
The goals of treatment are to [8]:
Reduce the frequency and severity of vertigo attacks
Reduce or eliminate hearing loss and tinnitus associated with attacks
Alleviate chronic symptoms (tinnitus and balance issues)Minimize disability
Prevent disease progression, particularly hearing loss and imbalance
Patient education is an important part of conservative management, and includes outlining an
explanation of the disease, expectations for response, and treatment options. Up to 90 percent of
patients with Meniere's disease are able to maintain normal daily activities with medical management.
Determining the optimal treatment for Meniere's disease is limited by the lack of randomized,
controlled trials [8,38]. In addition, drug therapy has been associated with a significant placebo effect
and the relapsing remitting nature of the disorder has made evaluation of various treatments difficult.
Vertigo attacks can be controlled in 90 to 95 percent of patients by conservative medical treatment,although progressive hearing loss rarely responds to treatment. Patients with suspected Meniere's
disease should be referred at a relatively early stage to an otologist/otolaryngologist.
NONINTERVENTIONAL TREATMENT Noninterventional treatment for Meniere's disease include
lifestyle adjustments, medical therapies, and rehabilitation.
Lifestyle adjustments Patients with Meniere's disease are more vulnerable to dietary and
environmental factors that can impact hearing and balance. Triggers for Meniere's disease may includ
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8%2C38http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=vasculit/4317&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=headache/4701&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=headache/8044&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=37 -
8/12/2019 Meniere's Disease PDF
6/22
5/31/10 3:2Meniere's disease
Page 6ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
high salt intake, caffeine, alcohol, nicotine, stress, monosodium glutamate (MSG), and allergies.
Avoidance for patients with identified triggers may alleviate or ameliorate symptoms.
Saltrestriction is commonly recommended as part of initial therapy [39,40], although data supporting
its efficacy are not available [8]. An appropriate salt-restricted diet will have approximately 2 to 3 g o
sodium per day. The daily sodium intake should be evenly spread across meals to avoid a large bolus
at any time. (See "Patient information: Low sodium diet".)
Caffeineand nicotineare vasoconstrictors that may reduce microvascular flow in the labyrinthinesystem. Alcohol also causes fluid and electrolyte shifts that can stress a fragile ear. Limiting caffeine t
one caffeinated beverage (coffee, tea, or cola) daily and limiting alcohol to one drink daily is typically
recommended.
Medical management
Acute episodes Acute episodes of vertigo should be managed with vestibular suppressants and
antiemetics (table 4). Doses should be started low and increased to positive effect or side effects.
(See "Treatment of vertigo".)
Vestibular suppressants include benzodiazepines, that have the advantage of anxiolytic properties for
short-term use, antihistamines (meclizineand dimenhydrinate), and anticholinergics (scopolamine).Promethazineand prochlorperazinemay be used for the acute treatment of severe nausea and
vomiting and are available in suppository form. Lorazepamhas been administered sublingually in "off-
label" usage. Although this has not been studied in clinical trials, otologists have found that a dose of
0.5 to 1 mg administered up to four times daily may achieve relief of acute vertigo attacks.
Rest and, if appropriate, volume repletion are important adjuvant therapies in the acute setting.
Drug therapy A number of medications have been used to treat Meniere's disease ( table 5).
Diuretics and as-needed vestibular suppressants/antiemetics are typically used when diet alone does
not adequately control the episodes. Combinations of these agents control episodes of vertigo in the
majority of patients, although they have not been shown to affect hearing loss [41].
Diuretics and betahistinehave been thought to reduce the degree of endolymphatic hydrops [39,42].
Betahistine, a vasodilator available in Europe, is reported to act by improving microvascular circulation
in the stria vascularis of the cochlea [43] or by inhibiting vestibular nuclei activity [44].
One review found that diuretics and betahistinehydrochloride were the only drugs with demonstrated
efficacy for long-term control of vertigo in double-blind studies [42]. However, two subsequent
systematic literature reviews found methodologic flaws in all trials, with no trials of either diuretics
[45] or betahistine [46] being of sufficient quality to meet the review standard for use. In the absenc
of better data and the low risk of adverse effects, we suggest use of diuretics when diet alone does
not adequately control episodes.
Use of systemic glucocorticoid therapy for Meniere's disease has been considered, based on the
possible immunologic etiology, and the role of steroids in patients with sudden sensorineural hearing
loss [8]. However, there are no randomized or prospective trials of oral glucocorticoids in patients wit
Meniere's disease [47]. Similarly, definitive studies are needed before immunosuppressive therapy wit
low dose methotrexate[48] or etanercept[49] can be recommended.
Patients have reported improvement with vitamin regimens, herbal remedies, and vasodilators.
However, these treatments are not supported by evidence of efficacy [8].
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=49http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/220502&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=48http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/162031&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=47http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=46http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=45http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=42http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/163444&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=44http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=43http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=39%2C42http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/163444&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=41http://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=PC%2F21583http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/147763&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/211521&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/212504&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/226665&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/212899&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/153350&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=genneuro/5875&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=NEURO%2F14542http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/180888&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/45920&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=kidn_dis/2514&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=39%2C40http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=nat_drug/72199&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/180888&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/45920&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/242996&source=see_link -
8/12/2019 Meniere's Disease PDF
7/22
5/31/10 3:2Meniere's disease
Page 7ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Rehabilitation Patients with Meniere's disease may be candidates for hearing aid use, vestibular
rehabilitation therapy, or other types of rehabilitation. Vestibular rehabilitation uses exercise activities
to maximize balance and central nervous system compensation for disequilibrium.
Vestibular rehabilitation has been used primarily in patients whose vertigo responded to medical or
surgical treatment, but who had residual disequilibrium. In a series of 26 patients who had responded
to treatment for vertigo prior to study inclusion, an eight week vestibular therapy program in a tertiar
referral center demonstrated a composite 25 percent improvement on four tests of disequilibrium [50
Vestibular rehabilitation may also be considered for untreated patients with Meniere's disease who
experience significant balance and disequilibrium symptoms between acute spells of vertigo [8].
However, there is no evidence of a reduction in the frequency or severity of vertigo attacks.
Hearing aids should be considered for patients with significant binaural hearing loss, but frustration du
to hearing fluctuation leads to poor patient compliance in this disorder.
INTERVENTIONAL TREATMENT Approximately 10 percent of patients have intractable or
progressive, unremitting symptoms that significantly impair their quality of life, despite medical
therapy. These individuals are candidates for invasive treatments.
The American Academy of Otolaryngology-Head and Neck Foundation (AAO-HNS) has set forth criteria
for Meniere's disease disability [26]:
Mild intermittent or continuous dizziness/unsteadiness that precludes working in a hazardous
environment.
Moderate intermittent or continuous dizziness that results in a sedentary occupation.
Severe disability symptoms so severe as to exclude gainful employment.
A self-assessment tool developed by the AAO-HNS, the Meniere's Disease Functional Level Scale (tabl
6), is useful in identifying patients who are candidates for interventional treatment to control vertigo,
and in assessing efficacy of therapy.
Interventional treatments for Meniere's syndrome include:
Destructive therapies, which act to reduce or eliminate signals from the affected labyrinthine
system to the brain
Nondestructive surgical treatments, whose mechanisms of action are unknown, but perhaps reduce
the accumulation of fluid in the endolymphatic spaces, or otherwise alter fluid and electrolyte
physiology.
There is no agreement on which procedures are first line therapy. The degree of labyrinthine function
and the level of hearing determine the best initial interventional treatment for an individual patient.
Destructive procedures Destructive procedures for the treatment of Meniere's disease include
intratympanic gentamicininjection, surgical labyrinthectomy, and vestibular nerve section. In general,
destructive techniques should are better suited to patients who have failed medical therapy and who
have unilateral disease. However, in cases of severe bilateral disease or intractable vertigo,
labyrinthine ablation must still be considered.
Intratympanic gentamicin Aminoglycosides are toxic to the sensory neuroepithelium of the
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/114920&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=PC%2F21265http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=26http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=50 -
8/12/2019 Meniere's Disease PDF
8/22
5/31/10 3:2Meniere's disease
Page 8ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
inner ear. (See "Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity".)
Gentamicindelivered into the middle ear space, by injection or cannula, allows the drug to locally
penetrate the labyrinth through the round window membrane and destroy hair cells in the semicircula
canals, ablating labyrinthine function on the treated side without adverse systemic effects.
Multiple applications of gentamicincontrol vertiginous symptoms of Meniere's disease in 80 to 90
percent of patients [51-54]. However, this therapy does not affect hydrops and the associated fullnes
hearing fluctuations, and sensory loss. Treatment is associated with a moderate risk of sensorineuralloss (up to 30 percent of patients) that is irreversible [55].
A newer technique uses a minimal dose of gentamicin(0.5 to 0.75 mL of a 40 mg/mL solution of
gentamicin) injected into the middle ear, with the intent to impact vestibular function without affecting
cochlear function. In one study, one transtympanic gentamicin injection resulted in good control of
vertigo in 76 percent of patients followed for four or more years, with minimal cochlear loss [56]. A
second injection was required in 15 to 20 percent of patients.
There is little consensus of the optimal protocol for intratympanic gentamicinadministration. One
meta-analysis found that titrating repeated gentamicin doses until a vestibular response is achieved is
superior to other treatment regimens [57], while another meta-analysis found no difference in
effectiveness for fixed dose or titration regimens, but noted significant quality issues in all trials
evaluated [58].
Labyrinthectomy Surgical destruction of the bony and membranous labyrinth by removal of all
of the neuroepithelium from the treated side relieves vertigo in virtually all patients but also causes
irreversible hearing loss in all patients [59]. Thus, it is only indicated in individuals with intractable
symptoms despite medical therapy who already have poor or complete hearing loss on the affected
side.
The concern of many physicians is that patients may have subclinical disease in the opposite ear that
will ultimately progress and cause total deafness. We do not believe that treatment should be withheld
in patients with disabling vertigo or drop attacks, for a potential and unpredictable future event.
Vestibular neurectomy Vestibular neurectomy involves surgical lysis of the vestibular nerve
bundle as it enters the internal auditory canal. It relieves vertigo in 90 to 95 percent of patients and i
associated with a low risk (10 to 20 percent) of sensorineural hearing loss [59].
However, vestibular neurectomy requires general anesthesia with craniotomy and overnight monitoring
in an intensive care unit, and is associated with significantly more morbidity than labyrinthectomy. Up
to 25 percent of patients experience postoperative headache, and 7 percent have a leak of
cerebrospinal fluid. In one series, hearing was preserved in 82 percent of patients undergoing this
procedure, although the gradual progression of deafness due to Meniere's was not altered [59].
Nondestructive procedures
Surgical The nondestructive surgical procedures include endolymphatic sac procedures
(enhancement or shunting or both) and sacculotomy. These procedures are associated with a low risk
of sensorineural hearing loss and are commonly performed for Meniere's disease in patients with intac
hearing, despite concerns that effectiveness may be due to placebo effect [60].
These procedures expose the endolymphatic sac and duct, with the aim to improve drainage of
endolymph. However, anatomic studies of the endolymphatic sac indicate that such drainage is not
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=60http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=59http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=59http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=59http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=58http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=57http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/114920&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=56http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/114920&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=55http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=51-54http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/114920&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/114920&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=renlfail/9988&source=see_link -
8/12/2019 Meniere's Disease PDF
9/22
5/31/10 3:2Meniere's disease
Page 9ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
plausible [61].
Control of vertigo has been reported in 75 to 80 percent of patients in uncontrolled case series [62-
66]. Symptomatic improvement in hearing and tinnitus have also been reported with apparent
longterm maintenance of benefits [65-67]. Installation of steroids into the endolymphatic sac following
drainage, in a controlled trial, did not affect the response rate for relief of vertigo symptoms but
increased the percent of patients who had some hearing improvement [65].
The only trial of endolymphatic shunt surgery that used sham surgery as a control concluded nodifference in effectiveness for the sham or interventional procedure [68]. These results have been
called into question with reanalysis that challenged both study design and statistical analysis [69].
Intratympanic glucocorticoids The possible immunologic basis for Meniere's disease, and use
of intratympanic glucocorticoids in treatment of sudden sensorineural hearing loss and in tinnitus, has
led to studies of intratympanic steroids in patients with intractable Meniere's disease.
In a prospective study of 21 patients, complete relief of vertigo was maintained in 9 patients (43
percent) at six months [70]. The complication rate was low, although repeated injection was often
necessary and the efficacy of the injection appeared to decrease over time.
A retrospective review of over 120 patients with two year follow-up showed that vertigo symptoms
could be controlled to a level that obviated need for destructive therapy in approximately 90 percent
[71].
Most studies have shown that vertigo symptoms may improve, without change in hearing or tinnitus
[8]. Optimal regimens for intratympanic glucocorticoids have not been developed, and further studies
are indicated.
Positive pressure pulse generator (Meniett) Positive pressure applied to the middle ear may
improve fluid exchange in the inner ear. Overpressure treatment, in which a device (Meniett pulse
generator) applies pulses of pressure to the middle ear via a ventilation tube, is an option for patient
who fail medical therapy or as an adjunct to medical therapy in patients with functional level 3 or
greater (table 6).
Several randomized double-blind placebo-controlled studies have shown shortterm efficacy and safety
of overpressure pulsing in the treatment of refractory Meniere's disease [72-74]. Longterm efficacy ha
also been demonstrated in two small studies with 67 percent [75] and 92 percent [76] of patients
maintaining improvement in vertigo symptoms at two-year follow-up. Maintenance of a patent
tympanostomy tube is required for overpressure treatment. The device is expensive, and does not
improve subjective hearing [8].
SUMMARY AND RECOMMENDATIONS
Meniere's disease is a clinical diagnosis, associated with hearing loss, episodic vertigo, and tinnitus
(See 'Introduction'above.)
Patients with Meniere's disease have endolymphatic hydrops in the labyrinthine system of the
affected ear. The etiology is unknown, but may be related to anatomic, immunologic, genetic, and/or
vascular factors. (See 'Pathogenesis'above.)
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H3http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H1http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=76http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=75http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=72-74http://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=PC%2F21265http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=71http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=70http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=69http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=68http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=65http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=65-67http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=62-66http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=61 -
8/12/2019 Meniere's Disease PDF
10/22
5/31/10 3:2Meniere's disease
Page 10ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Sensorineural hearing loss is fluctuating and progressive. Vertigo episodes last from 20 minutes to
24 hours, and typically occur in clusters. Aural fullness and nausea may be associated with other
symptoms. Symptoms are cyclical and prolonged periods of remission are typical. (See 'Clinical
features'above.)
Meniere's disease is a clinical diagnosis. Although not diagnostic, patients should undergo
audiometry, vestibular testing, and MRI to rule out other causes of symptoms (table 2). The vestibula
evoked myogenic potential (VEMP) test may be useful for monitoring disease progression. (See'Diagnosis'above.)
Meniere's disease is a chronic condition; patients should be given reasonable expectations of
treatment, which include symptom relief but not cure. Patients with suspected Meniere's disease shou
be referred at a relatively early stage to an otologist/otolaryngologist. (See 'Principles of
treatment'above.)
We suggest that patients limit intake of salt, caffeine, nicotine, and alcohol (Grade 2C). Acute
symptoms of vertigo should be managed with appropriate medication (table 4). We suggest use of
diuretics when diet alone does not adequately control episodes (Grade 2C). Vestibular rehabilitationmay help patients with residual disequilibrium, and hearing aids can improve hearing in compliant
patients. (See 'Noninterventional treatment'above.)
Interventional therapy may be indicated in the 5 to 10 percent of patients who have intractable
vertigo symptoms that significantly impair quality of life despite aggressive medical management. The
degree of labyrinthine function and level of hearing determine the best initial interventional treatment
for an individual patient.
Interventional techniques include destructive procedures (intratympanic gentamicin, labyrinthectomy,
and vestibular neurectomy) and nondestructive procedures. Endolymphatic sac surgery has been
effective for patients with intact hearing in prospective series, although a placebo response has beenimplicated. Intratympanic glucocorticoids may improve vertigo symptoms, but await controlled trials. A
positive pressure pulse generator has demonstrated longterm effectiveness but requires a patent
tympanostomy and is expensive. (See 'Interventional treatment'above.)
Use of UpToDate is subject to the Subscription and License Agreement.
REFERENCES
1. Meniere, P. Congestions cerebrales apoplectiformes. Gaz md Paris 1861; 16:55.
2. Meyerhoff, WL, Paparella, MM, Shea, D. Meniere's disease in children. Laryngoscope 1978;88:1504.
3. Jackler, RK, Luxford, WM, Brackmann, DE, Monsell, EM. Endolymphatic sac surgery in congenital
malformations of the inner ear. Laryngoscope 1988; 98:698.
4. Schessel, DA, Minor, LB, Nedzelski, J. Meniere's disease and other peripheral vestibular disorders
In: Cummings CW (Ed), Otolaryngology Head and Neck Surgery, St Louis, Mosby 1998. p.2672.
5. Balkany, TJ, Sires, B, Arenberg, IK. Bilateral aspects of Meniere's disease: an underestimated
clinical entity. Otolaryngol Clin North Am 1980; 13:603.
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=3http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=2http://www.uptodate.com.offcampus.lib.washington.edu/online/license.htmlhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H19http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/114920&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H13http://www.uptodate.com.offcampus.lib.washington.edu/online/content/grade.do?gradeId=6&title=Grade+2Chttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=NEURO%2F14542http://www.uptodate.com.offcampus.lib.washington.edu/online/content/grade.do?gradeId=6&title=Grade+2Chttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_l_z/180888&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=drug_a_k/45920&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=nat_drug/72199&source=see_linkhttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H12http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H5http://www.uptodate.com.offcampus.lib.washington.edu/online/content/image.do?imageKey=PC%2F20819http://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print#H4 -
8/12/2019 Meniere's Disease PDF
11/22
5/31/10 3:2Meniere's disease
Page 11ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
6. Enander, A, Stahle, J. Hearing in Meniere's disease. A study of pure-tone audiograms in 334
patients. Acta Otolaryngol 1967; 64:543.
7. Mizukoshi, K, Ino, H, Ishikawa, K, et al. Epidemiological survey of definite cases of Meniere's
disease collected by the seventeen members of the Meniere's Disease Research Committee of
Japan in 1975--1976. Adv Otorhinolaryngol 1979; 25:106.
8. Coelho, DH, Lalwani, AK. Medical Management Of Meniere's Disease. Laryngoscope 2008;
118:1099.
9. Kimura, RS. Experimental blockage of the endolymphatic duct and sac and its effect on the inneear of the guinea pig. A study on endolymphatic hydrops. Ann Otol Rhinol Laryngol 1967; 76:66
10. Yamamoto, E, Mizukami, C. Development of the vestibular aqueduct in Meniere's disease. Acta
Otolaryngol Suppl 1993; 504:46.
11. Alleman, AM, Dornhoffer, JL, Arenberg, IK, Walker, PD. Demonstration of autoantibodies to the
endolymphatic sac in Meniere's disease. Laryngoscope 1997; 107:211.
12. Evans, KL, Baldwin, DL, Bainbridge, D, Morrison, AW. Immune status in patients with Meniere's
disease. Arch Otorhinolaryngol 1988; 245:287.
13. Brookes, GB. Circulating immune complexes in Meniere's disease. Arch Otolaryngol Head Neck
Surg 1986; 112:536.
14. Morrison, AW. Anticipation in Meniere's disease. J Laryngol Otol 1995; 109:499.15. Klockars, T, Kentala, E. Inheritance of Meniere's disease in the Finnish population. Arch
Otolaryngol Head Neck Surg 2007; 133:73.
16. Calenoff, E, Zhao, JC, Derlacki, EL, et al. Patients with Meniere's disease possess IgE reacting
with herpes family viruses. Arch Otolaryngol Head Neck Surg 1995; 121:861.
17. Welling, DB, Daniels, RL, Brainard, J, et al. Detection of viral DNA in endolymphatic sac tissue
from Meniere's disease patients. Am J Otol 1994; 15:639.
18. Parker, W. Meniere's disease. Etiologic considerations. Arch Otolaryngol Head Neck Surg 1995;
121:377.
19. Radtke, A, Lempert, T, Gresty, MA, et al. Migraine and Meniere's disease: is there a link?.
Neurology 2002; 59:1700.20. Lawrence, M, McCabe, BF. Inner-ear mechanics and deafness. Special consideration of Meniere's
syndrome. J Am Med Assoc 1959; 171:1927.
21. Schuknecht, H. Meniere's disease. J Otolaryngol Soc Aust 1963; 30:222.
22. Duvall AJ, 3rd, Santi, PA, Hukee, MJ. Cochlear fluid balance. A clinical/research overview. Ann
Otol Rhinol Laryngol 1980; 89:335.
23. Brown, DH, McClure, JA, Downar-Zapolski, Z. The membrane rupture theory of Meniere's disease
-is it valid?. Laryngoscope 1988; 98:599.
24. Saeed, SR. Fortnightly review. Diagnosis and treatment of Meniere's disease. BMJ 1998; 316:368
25. Perez-Garrigues, H, Lopez-Escamez, JA, Perez, P, et al. Time course of episodes of definitive
vertigo in Meniere's disease. Arch Otolaryngol Head Neck Surg 2008; 134:1149.
26. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in
Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc.
Otolaryngol Head Neck Surg 1995; 113:181.
27. Gottschlich, S, Billings, PB, Keithley, EM, et al. Assessment of serum antibodies in patients with
rapidly progressive sensorineural hearing loss and Meniere's disease. Laryngoscope 1995;
105:1347.
28. Bloch, DB, San Martin, JE, Rauch, SD, et al. Serum antibodies to heat shock protein 70 in
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=28http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=27http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=25http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=23http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=22http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=18http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=17http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=16http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=15http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=14http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=13http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=12http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=11http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=10http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=8http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=7 -
8/12/2019 Meniere's Disease PDF
12/22
5/31/10 3:2Meniere's disease
Page 12ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 1995; 121:1167.
29. Shin, SO, Billings, PB, Keithley, EM, Harris, JP. Comparison of anti-heat shock protein 70 (anti-
hsp70) and anti-68-kDa inner ear protein in the sera of patients with Meniere's disease.
Laryngoscope 1997; 107:222.
30. Lorenzi, MC, Bento, RF, Daniel, MM, Leite, CC. Magnetic resonance imaging of the temporal bone
in patients with Meniere's disease. Acta Otolaryngol 2000; 120:615.
31. Yen, PT, Lin, CC, Huang, TS. A preliminary report on the correlation of vestibular Meniere's
disease with electrocochleography and glycerol test. Acta Otolaryngol Suppl 1995; 520 Pt 2:241.
32. Conlon, BJ, Gibson, WP. Electrocochleography in the diagnosis of Meniere's disease. Acta
Otolaryngol 2000; 120:480.
33. Rauch, SD, Zhou, G, Kujawa, SG, et al. Vestibular evoked myogenic potentials show altered
tuning in patients with Meniere's disease. Otol Neurotol 2004; 25:333.
34. Lin, MY, Timmer, FC, Oriel, BS, et al. Vestibular evoked myogenic potentials (VEMP) can detect
asymptomatic saccular hydrops. Laryngoscope 2006; 116:987.
35. Boyev, KP. Meniere's disease or migraine? The clinical significance of fluctuating hearing loss wit
vertigo. Arch Otolaryngol Head Neck Surg 2005; 131:457.
36. Wladislavosky-Waserman, P, Facer, GW, Mokri, B, Kurland, LT. Meniere's disease: a 30-year
epidemiologic and clinical study in Rochester, Mn, 1951-1980. Laryngoscope 1984; 94:1098.37. Headache Classification Subcommittee of the International Headache Society. The International
Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24(Suppl 1):9.
38. Thorp, MA, Shehab, ZP, Bance, ML, Rutka, JA. Does evidence-based medicine exist in the
treatment of Meniere's disease? A critical review of the last decade of publications. Clin
Otolaryngol 2000; 25:456.
39. Santos, PM. Diuretic and diet effect on Meniere's disease evaluated by the 1985 Committee on
Hearing and Equilibrium guidelines. Otolaryngol Head Neck Surg 1993; 109:680.
40. Boles, R, Rice, DH, Hybels, R, Work, WP. Conservative management of Meniere's disease:
Furstenberg regimen revisited. Ann Otol Rhinol Laryngol 1975; 84:513.
41. Kinney, SE, Sandridge, SA, Newman, CW. Long-term effects of Meniere's disease on hearing andquality of life. Am J Otol 1997; 18:67.
42. Claes, J, Van de, Heyning PH. A review of medical treatment for Meniere's disease. Acta
Otolaryngol Suppl 2000; 544:34.
43. Martinez, DM. The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in
experimental animals. Acta Otolaryngol Suppl 1972; 305:29.
44. Timmerman, H. Pharmacotherapy of vertigo: any news to be expected?. Acta Otolaryngol Suppl
1994; 513:28.
45. Thirlwall, AS, Kundu, S. Diuretics for Meniere's disease or syndrome. Cochrane Database Syst Re
2006; 3:CD003599.
46. James, AL, Burton, MJ. Betahistine for Meniere's disease or syndrome. Cochrane Database SystRev 2001; :CD001873.
47. Cope, D, Bova, R. Steroids in otolaryngology. Laryngoscope 2008; 118:1556.
48. Kilpatrick, JK, Sismanis, A, Spencer, RF, Wise, CM. Low-dose oral methotrexate management of
patients with bilateral Meniere's disease. Ear Nose Throat J 2000; 79:82.
49. Rahman, MU, Poe, DS, Choi, HK. Etanercept therapy for immune-mediated cochleovestibular
disorders: preliminary results in a pilot study. Otol Neurotol 2001; 22:619.
50. Gottshall, KR, Hoffer, ME, Moore, RJ, Balough, BJ. The role of vestibular rehabilitation in the
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=50http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=49http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=48http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=47http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=46http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=45http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=44http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=42http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=41http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=40http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=39http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=38http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=36http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=34http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=33http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=32http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=31http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=30http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=29http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=28 -
8/12/2019 Meniere's Disease PDF
13/22
5/31/10 3:2Meniere's disease
Page 13ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
treatment of Meniere's disease. Otolaryngol Head Neck Surg 2005; 133:326.
51. Nedzelski, JM, Schessel, DA, Bryce, GE, Pfleiderer, AG. Chemical labyrinthectomy: local
application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992;
13:18.
52. Quaranta, A, Aloisi, A, De Benedittis, G, Scaringi, A. Intratympanic therapy for Meniere's disease
High-concentration gentamicin with round-window protection. Ann N Y Acad Sci 1999; 884:410.
53. Perez, N, Martin, E, Garcia-Tapia, R. Intratympanic gentamicin for intractable Meniere's disease.
Laryngoscope 2003; 113:456.
54. Boleas-Aguirre, MS, Sanchez-Ferrandiz, N, Guillen-Grima, F, Perez, N. Long-term disability of
class A patients with Meniere's disease after treatment with intratympanic gentamicin.
Laryngoscope 2007; 117:1474.
55. Blakley, BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000;
110:236.
56. Harner, SG, Driscoll, CL, Facer, GW, et al. Long-term follow-up of transtympanic gentamicin for
Meniere's syndrome. Otol Neurotol 2001; 22:210.
57. Chia, SH, Gamst, AC, Anderson, JP, Harris, JP. Intratympanic gentamicin therapy for Meniere's
disease: a meta-analysis. Otol Neurotol 2004; 25:544.
58. Cohen-Kerem, R, Kisilevsky, V, Einarson, TR, et al. Intratympanic gentamicin for Meniere'sdisease: a meta-analysis. Laryngoscope 2004; 114:2085.
59. Gacek, RR, Gacek, MR. Comparison of labyrinthectomy and vestibular neurectomy in the control
of vertigo. Laryngoscope 1996; 106:225.
60. Kim, HH, Wiet, RJ, Battista, RA. Trends in the diagnosis and the management of Meniere's
disease: results of a survey. Otolaryngol Head Neck Surg 2005; 132:722.
61. Friberg, U, Jansson, B, Rask-Andersen, H, Bagger-Sjoback, D. Variations in surgical anatomy of
the endolymphatic sac. Arch Otolaryngol Head Neck Surg 1988; 114:389.
62. Moffat, DA. Endolymphatic sac surgery: analysis of 100 operations. Clin Otolaryngol 1994;
19:261.
63. Telischi, FF, Luxford, WM. Long-term efficacy of endolymphatic sac surgery for vertigo inMeniere's disease. Otolaryngol Head Neck Surg 1993; 109:83.
64. Brinson, GM, Chen, DA, Arriaga, MA. Endolymphatic mastoid shunt versus endolymphatic sac
decompression for Meniere's disease. Otolaryngol Head Neck Surg 2007; 136:415.
65. Kitahara, T, Kubo, T, Okumura, S, Kitahara, M. Effects of endolymphatic sac drainage with
steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study
Laryngoscope 2008; 118:854.
66. Wetmore, SJ. Endolymphatic sac surgery for Meniere's disease: long-term results after primary
and revision surgery. Arch Otolaryngol Head Neck Surg 2008; 134:1144.
67. Ostrowski, VB, Kartush, JM. Endolymphatic sac-vein decompression for intractable meniere's
disease: Long term treatment results. Otolaryngol Head Neck Surg 2003; 128:550.
68. Thomsen, J, Bretlau, P, Tos, M, Johnsen, NJ. Placebo effect in surgery for Meniere's disease. A
double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol
1981; 107:271.
69. Welling, DB, Nagaraja, HN. Endolymphatic mastoid shunt: a reevaluation of efficacy. Otolaryngol
Head Neck Surg 2000; 122:340.
70. Barrs, DM, Keyser, JS, Stallworth, C, McElveen, JT Jr. Intratympanic steroid injections for
intractable Meniere's Disease. Laryngoscope 2001; 111:2100.
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=70http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=69http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=68http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=67http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=66http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=65http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=64http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=63http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=62http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=61http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=60http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=59http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=58http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=57http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=56http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=55http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=54http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=53http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=52http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=51http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=50 -
8/12/2019 Meniere's Disease PDF
14/22
5/31/10 3:2Meniere's disease
Page 14ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
71. Boleas-Aguirre, MS, Lin, FR, Della Santina, CC, et al. Longitudinal results with intratympanic
dexamethasone in the treatment of Meniere's disease. Otol Neurotol 2008; 29:33.
72. Thomsen, J, Sass, K, Odkvist, L, Arlinger, S. Local overpressure treatment reduces vestibular
symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind,
placebo-controlled study. Otol Neurotol 2005; 26:68.
73. Gates, GA, Green, JD Jr, Tucci, DL, Telian, SA. The effects of transtympanic micropressure
treatment in people with unilateral Meniere's disease. Arch Otolaryngol Head Neck Surg 2004;
130:718.74. Odkvist, LM, Arlinger, S, Billermark, E, et al. Effects of middle ear pressure changes on clinical
symptoms in patients with Meniere's disease--a clinical multicentre placebo-controlled study. Acta
Otolaryngol Suppl 2000; 543:99.
75. Gates, GA, Verrall, A, Green, JD Jr, et al. Meniett clinical trial: long-term follow-up. Arch
Otolaryngol Head Neck Surg 2006; 132:1311.
76. Densert, B, Sass, K. Control of symptoms in patients with Meniere's disease using middle ear
pressure applications: two years follow-up. Acta Otolaryngol 2001; 121:616.
http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=76http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=75http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=74http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=73http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=72http://www.uptodate.com.offcampus.lib.washington.edu/online/content/abstract.do?topicKey=prim_ent%2F9407&refNum=71 -
8/12/2019 Meniere's Disease PDF
15/22
5/31/10 3:2Meniere's disease
Page 15ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
GRAPHICS
-
8/12/2019 Meniere's Disease PDF
16/22
5/31/10 3:2Meniere's disease
Page 16ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Causes of endolymphatic hydrops*
Acoustic trauma
Autoimmune inner ear disease
Chronic otitis media
Cogan's syndrome
Congenital deafness
Endolymphatic sac tumors
Fenestration of the otic capsule
Labyrinthine concussion
Letterer-Siwe disease
Leukemic infiltrates
Mondini dysplasia
Otosclerosis
Paget's disease
Serous labyrinthitis
Surgical trauma to inner ear
Syphilis
Temporal bone/head trauma
Viral labyrinthitis
* Endolymphatic hydrops determined at autopsy.
Adapted from Jackler, RK, Brackmann, DE, Eds, Neurotology, Mosby Year Book Inc, Missouri
1994, p. 635.
-
8/12/2019 Meniere's Disease PDF
17/22
5/31/10 3:2Meniere's disease
Page 17ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Conditions that may cause symptoms of Meniere's syndrome
Hyper/hypothyroidism
Diabetes
Central nervous system disease (eg, cerebral vascular insufficiency, aneurysm, multiple
sclerosis, concussive syndrome, tumor, pseudotumor cerebri)
Recurrent vestibular neuronitis
Autoimmune disease
Neurosyphilis
-
8/12/2019 Meniere's Disease PDF
18/22
5/31/10 3:2Meniere's disease
Page 18ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Differential diagnosis for Meniere's disease
Central nervous system
Acoustic neuroma
Multiple sclerosis
Vascular loop compression of eighth nerve
Basilar/vertebral artery insufficiency
Arnold-Chiari malformation
Cerebellar tumors
Transient ischemic attacks
Peripheral vestibular system
Benign positional vertigo
Syphilitic endolymphatic hydrops
Post-concussive hydrops
Post-infectious hydrops (history of sudden sensorineural hearing loss, chronic otitis media, or
labyrinthitis)
Autoimmune inner ear disease
Perilymphatic fistula
Otosclerosis
Migraine induced vertigo
Other
Diabetes
Thyroid disease
Cogan's syndrome
Anemia
-
8/12/2019 Meniere's Disease PDF
19/22
-
8/12/2019 Meniere's Disease PDF
20/22
5/31/10 3:2Meniere's disease
Page 20ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Medications used to treat Meniere's disease
Diuretics
Hydrochlorthiazide
Hydrochlorthiazide and triamterene (Maxzide, Dyazide)
Acetazolamide (Diamox)
Methazolamide (Neptazane)
Antiemetics
Meclizine
Dimenhydrinate (Dramamine)
Prochlorperazine (Compazine)
Promethazine (Phenergan)
Anxiolytics (suppress the central vestibular response)
Diazepam (Valium)
Lorazepam (Ativan)
Alprazolam (Xanax)
Thorazine
Chlorpromazine
Immunomodulators (for acute severe exacerbations and patients withautoimmune antibodies)
Prednisone
Dexamethasone
Methotrexate
Antihistamines (in patients with concomittant allergy or food allergy)
Diphenhydramine (Benadryl)
Loratadine (Claritin)
Fexofenadrine (Allegra)
Ceftirizine (Zyrtec)
Hydroxyzine (Vistaril)
Ototoxic antibiotics
-
8/12/2019 Meniere's Disease PDF
21/22
5/31/10 3:2Meniere's disease
Page 21ttp://www.uptodate.com.offcampus.lib.washington.edu/online/content/topic.do?topicKey=prim_ent/9407&view=print
Gentamicin
Streptomycin
Others
Betahistine
Scopolamine
-
8/12/2019 Meniere's Disease PDF
22/22
5/31/10 3:2Meniere's disease
Functional level scale
Regarding my current state of overall function, not just during attacks(check the ONE that best applies):
1. My dizziness has no effect on my activities at all.
2. When I am dizzy I have to stop what I am doing for a while, but it soon passes and I
can resume activities. I continue to work, drive, and engage in any activity I choose withoutrestriction. I have not changed any plans or activities to accommodate my dizziness.
3. When I am dizzy I have to stop what I am doing for a while, but it does pass and I can
resume activities. I continue to work, drive, and engage in most activities I choose, but I
have had to change some plans and make some allowance for my dizziness.
4. I am able to work, drive, travel, take care of a family, or engage in most essential
activities, but I must exert a great deal of effort to do so. I must constantly make
adjustments in my activities and budget my energies. I am barely making it.
5. I am unable to work, drive, or take care of a family. I am unable to do most of the
active things that I used to. Even essential activities must be limited. I am disabled.
6. I have been disabled for 1 year or longer and/or I receive compensation (money)
because of my dizziness or balance problem.
Reproduced with permission from: Committee on Hearing and Equilibrium guidelines for the
diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-
Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995; 113:181. Copyright 1995
American Academy of Otolaryngology-Head and Neck Surgery.
2010 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Support Tag:
[ecapp1002p.utd.com-128.95.104.109-EBA4105701-1514]Licensed to: Univ Of Washington
http://www.uptodate.com.offcampus.lib.washington.edu/online/license.html